Foundation models of life, for life.
Inceptive builds foundation AI models for biological drug discovery, training end-to-end on heterogeneous multi-scale data spanning sequence, structure, and function. The company partners with leading pharmaceutical firms to co-design novel RNA-based drug candidates that outperform existing molecules. Founded in 2021 by AI and biochemistry pioneers, Inceptive has offices in Palo Alto, Berlin, and Zurich.
Tech & App Stack is available on paid plans
Upgrade to Silver or higher to reveal the full technology and app stack for any company.
View pricingCreate a free account to see funding visualizations and detailed round data.
Create Free AccountSep 2023
Sep 2022
Create a free account to see which investors have funded this company.
Create Free AccountAI-first drug discovery company using AlphaFold-derived models to design therapeutics and acceler...
Asymchem provides R&D and one-stop production services to the world's top pharmaceutical companies.
Next-gen Medicare Advantage insurance plan with AI-forward medical group delivering quality and s...
South Korean biotech company and global leader in medical aesthetics, manufacturing botulinum tox...
Global full-service clinical research organization (CRO) and scientific advisory partner for biot...
OpenAI is an AI research and deployment company dedicated to ensuring that general-purpose artifi...
